Newsroom | 20770 results

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements mark a new era for New Jersey’s innovation economy—with GSVP emerging as a key catalyst behind both....

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, will present significant additions to its comprehensive portfolio of Radiation Therapy Quality Management solutions at the 2025 American Association of Physicists in Medicine (AAPM) Annual Meeting, taking place July 27-29, in Washington, D.C. Attendees are invited to explore new software and hardware innovations designed to help elevate treatment quality, streamline workflows, and support safer care. Premiering at AAPM 202...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that it is proposing to raise up to $2,500,000 by way of a Non-Brokered Private Placement of up to 33,333,334 Units at $0.075 per Unit (“Unit”). Each Unit will be comprised of One (1) fully paid common share and One-half (1/2) of a Share Purchase Warrant; each whole Share Purchase Warrants (“Warrant(s)”) will be exercisable to purchase One (1) further Common Share at the price...

東京--(BUSINESS WIRE)--(美國商業資訊)-- 專注於內視鏡AI診斷技術研發的醫療初創企業AI MEDICAL SERVICE INC.（以下簡稱「AIM」）欣然宣布，已於2025年6月26日獲得泰國食品藥物管理局（泰國FDA）的醫療器材核准。此次獲准的是該公司的內視鏡影像診斷支援軟體「gastroAI-model G」。該系統利用人工智慧技術，輔助醫生在內視鏡影像中區分腫瘤性與非腫瘤性胃部病變。這代表泰國第一個具備病變區分1能力的上消化道AI診斷支援系統獲得監管核准2。 我們在泰國完成監管審查與器材註冊工作的背景情況 胃癌是全球第五大常見癌症，每年新增病例超過100萬，死亡人數約60萬3。胃癌的特點是，其死亡率會隨著病情的進展而顯著上升。然而，胃癌若能在早期被發現，往往是可以治療的；第一期胃癌病患的5年相對生存率約為95%，而第三期及以後病患的生存率不足50%4。儘管如此，早期胃癌難以檢測，據統計，其漏診率高達4.5%至25.8%5。 在泰國，胃癌死亡率居高不下（約75%6的確診病患死於該疾病），這顯示許多病例在確診時已處於晚期。這一醫療挑戰還因顯著的人口結構趨勢而加...

东京--(BUSINESS WIRE)--(美国商业资讯)-- 专注于内窥镜AI诊断技术研发的医疗初创企业AI MEDICAL SERVICE INC.（以下简称“AIM”）欣然宣布，已于2025年6月26日获得泰国食品药品管理局（泰国FDA）的医疗器械批准。此次获批的是该公司的内窥镜影像诊断支持软件“gastroAI-model G”。该系统利用人工智能技术，辅助医生在内窥镜影像中区分肿瘤性与非肿瘤性胃部病变。这标志着泰国首个具备病变区分1能力的上消化道AI诊断支持系统获得监管批准2。 我们在泰国完成监管审查与器械注册工作的背景情况 胃癌是全球第五大常见癌症，每年新增病例超过100万，死亡人数约60万3。胃癌的特点是，其死亡率会随着病情的进展而显著上升。然而，胃癌若能在早期被发现，往往是可以治疗的；Ⅰ期胃癌患者的5年相对生存率约为95%，而Ⅲ期及以后患者的生存率不足50%4。尽管如此，早期胃癌难以检测，据统计，其漏诊率高达4.5%至25.85。 在泰国，胃癌死亡率居高不下（约75%6的确诊患者死于该疾病），这表明许多病例在确诊时已处于晚期。这一医疗挑战还因显著的人口结构趋势而加剧：作...

AUSTIN, Texas--(BUSINESS WIRE)--Revival Healthcare Capital Announces Strategic Partnership with Olympus to Jointly Invest up to $458 Million into Swan EndoSurgical....

DUBLIN--(BUSINESS WIRE)--The "The Global Wearable Technology Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The Global Wearable Technology Market 2026-2036 is a comprehensive 1,200-page market report providing an exhaustive analysis of the wearable technology ecosystem from 2026 to 2036, offering unprecedented insights into market dynamics, emerging technologies, and future growth opportunities across consumer electronics, medical applications, and industrial sect...

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2025, before the market opens on Thursday, August 7, 2025, and will host a conference call at 8:30 am ET that day to discuss those results. To participate in the conference call, dial (416) 764 8646 (U.S. and Ca...

PLYMOUTH, Mass.--(BUSINESS WIRE)--The Vascular Care Group Welcomes Dr. Scott James as Newest Physician Partner...

TOKYO--(BUSINESS WIRE)--AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce that it has received medical device approval from the Thai Food and Drug Administration (Thai FDA) on June 26, 2025. The approval is for its endoscopic image diagnosis support software, the "gastroAI-model G." This system utilizes artificial intelligence to assist physicians in differentiating between neoplastic and non-neoplas...